Lawrence S. Kegeles

Lawrence S. Kegeles publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Lawrence S. Kegeles sits on this spectrum.

Lawrence S. Kegeles D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Lawrence S. Kegeles sits on this spectrum.

Best Publications

• Increased baseline occupancy of D2 receptors by dopamine in schizophrenia.

  Anissa Abi-Dargham;Janine Rodenhiser;David Printz;Yolanda Zea-Ponce

  1365
  Citations

• Increased dopamine transmission in schizophrenia: relationship to illness phases.

  Marc Laruelle;Anissa Abi-Dargham;Anissa Abi-Dargham;Roberto Gil;Roberto Gil;Lawrence Kegeles

  903
  Citations

• Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum.

  Diana Martinez;Mark Slifstein;Allegra Broft;Osama Mawlawi

  644
  Citations

• Increased synaptic dopamine function in associative regions of the striatum in schizophrenia.

  Lawrence S. Kegeles;Anissa Abi-Dargham;W. Gordon Frankle;Roberto Gil

  636
  Citations

• Glutamate, Dopamine, and Schizophrenia

  Marc Laruelle;Lawrence S. Kegeles;Anissa Abi-Dargham

  618
  Citations

• Alcohol Dependence Is Associated with Blunted Dopamine Transmission in the Ventral Striatum

  Diana Martinez;Roberto Gil;Mark Slifstein;Dah Ren Hwang

  534
  Citations

• Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia.

  Lawrence S Kegeles;Anissa Abi-Dargham;Yolanda Zea-Ponce;Janine Rodenhiser-Hill

  481
  Citations

• Decreased Regional Brain Metabolism After ECT

  Mitchell S. Nobler;Maria A. Oquendo;Lawrence S. Kegeles;Kevin M. Malone

  456
  Citations

• Positron emission tomography of regional brain metabolic responses to a serotonergic challenge and lethality of suicide attempts in major depression.

  Maria A. Oquendo;Giovanni P. A. Placidi;Kevin M. Malone;Carl Campbell

  405
  Citations

• Hippocampal dysfunction in the pathophysiology of schizophrenia: a selective review and hypothesis for early detection and intervention

  J A Lieberman;J A Lieberman;R R Girgis;R R Girgis;G Brucato;G Brucato;H Moore;H Moore

  404
  Citations

• Randomized Controlled Crossover Trial of Ketamine in Obsessive-Compulsive Disorder: Proof-of-Concept

  Carolyn I Rodriguez;Lawrence S Kegeles;Lawrence S Kegeles;Amanda Levinson;Tianshu Feng;Tianshu Feng

  361
  Citations

• Elevated prefrontal cortex γ-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy.

  Lawrence S. Kegeles;Xiangling Mao;Arielle D. Stanford;Ragy Girgis

  348
  Citations

• Pathway-Specific Dopamine Abnormalities in Schizophrenia.

  Jodi J. Weinstein;Muhammad O. Chohan;Mark Slifstein;Lawrence S. Kegeles

  324
  Citations

• Sex Differences in Striatal Dopamine Release in Young Adults After Oral Alcohol Challenge: A Positron Emission Tomography Imaging Study With [11C]Raclopride

  Nina B.L. Urban;Lawrence S. Kegeles;Mark Slifstein;Xiaoyan Xu

  267
  Citations

• Baseline and Amphetamine-Stimulated Dopamine Activity Are Related in Drug-Naïve Schizophrenic Subjects

  Anissa Abi-Dargham;Elsmarieke van de Giessen;Elsmarieke van de Giessen;Mark Slifstein;Lawrence S. Kegeles

  250
  Citations

• Imaging glutamate in schizophrenia: review of findings and implications for drug discovery.

  E M P Poels;L S Kegeles;J T Kantrowitz;M Slifstein

  249
  Citations

• Neuromelanin-sensitive MRI as a noninvasive proxy measure of dopamine function in the human brain.

  Clifford M. Cassidy;Clifford M. Cassidy;Fabio A. Zucca;Ragy R. Girgis;Seth C. Baker

  239
  Citations

• In vivo vulnerability to competition by endogenous dopamine: comparison of the D2 receptor agonist radiotracer (-)-N-[11C]propyl-norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]-raclopride.

  Rajesh Narendran;Dah Ren Hwang;Mark Slifstein;Peter S. Talbot

  226
  Citations

• GABA level, gamma oscillation, and working memory performance in schizophrenia

  Chi-Ming A. Chen;Arielle D. Stanford;Xiangling Mao;Anissa Abi-Dargham

  214
  Citations

• Comparative evaluation in nonhuman primates of five PET radiotracers for imaging the serotonin transporters: [11C]McN 5652, [11C]ADAM, [11C]DASB, [11C]DAPA, and [11C]AFM.

  Yiyun Huang;Dah Ren Hwang;Raj Narendran;Yasuhiko Sudo

  211
  Citations